• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Merck Ltd/India

+ Add to Watchlist

EMER:IN

769.80 INR 0.85 0.11%

As of 07:06:16 ET on 08/21/2014.

Snapshot for Merck Ltd/India (EMER)

Open: 771.25 Day's Range: 761.20 - 787.00 Volume: 26,819
Previous Close: 770.65 52wk Range: 522.60 - 880.60 1-Yr Rtn: +43.30%

Stock Chart for EMER

No chart data available.
  • EMER:IN 769.80
  • 1D
  • 1M
  • 1Y
770.65
Interactive EMER Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EMER

Current P/E Ratio (ttm) 22.8427
Estimated P/E(-) -
Relative P/E vs. SENSEX 1.2457
Earnings Per Share (ttm) 33.7000
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 12,778.20
Shares Outstanding (M) 16.60
30 Day Average Volume 56,519
Price/Book (mrq) 2.4431
Price/Sale (ttm) 1.6522
Dividend Indicated Gross Yield 1.10%
Cash Dividend (INR) 8.5000
Dividend Ex-Date 03/10/2014
5 Year Dividend Growth -13.45%
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EMER

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for EMER

Merck Ltd. manufactures pharmaceutical drugs, reagents, bulk drugs, diagnostic equipment, pigments, chemicals, and pesticides. The Company's major products include neurotropic specialties such as encephabol, anti-psychotics such as l ithocarb and vitamin formulations such as neurobion, polybion, multiboonata, e tc.

Claus Dieter BoedeckerManaging DirectorN KrishnanExecutive Director
Pramod H PimplikarExecutive DirectorVikas R GuptaSecy/Gen Cnsl/Compliance Ofcr
More Company Profile & Key Executives for EMER

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil